Owlet (OWLT) Cash from Operations Growth (1y) (2021 - 2026)
Owlet (OWLT) Cash from Operations Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn | -7.20% |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn | 132.40% |
| 3 | Medtronic | 108.74 Bn | 99.52 Bn | 6.41 Bn | 1.78% |
| 4 | Boston Scientific | 68.40 Bn | 66.95 Bn | 3.61 Bn | -35.67% |
| 5 | Edwards Lifesciences | 47.42 Bn | 43.74 Bn | 1.29 Bn | -84.38% |
| 6 | GE HealthCare Technologies | 28.47 Bn | 26.18 Bn | 1.98 Bn | 16.00% |
| 7 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | 185.96% |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.39 Bn | 2.07 Bn | 122.43% |
| 10 | Owlet | 147.09 Mn | 106.08 Mn | 12.24 Mn | 14.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.78% |
| Dec 31, 2025 | -115.04% |
| Sep 30, 2025 | 71.04% |
| Jun 30, 2025 | 33.28% |
| Mar 31, 2025 | -76.55% |
| Dec 31, 2024 | 290.74% |
| Sep 30, 2024 | -44.28% |
| Jun 30, 2024 | 54.42% |
| Mar 31, 2024 | 64.20% |
| Dec 31, 2023 | 83.96% |
| Sep 30, 2023 | 67.32% |
| Jun 30, 2023 | 73.88% |
| Mar 31, 2023 | 65.78% |
| Dec 31, 2022 | -67.86% |
| Sep 30, 2022 | 16.76% |
| Jun 30, 2022 | -227.43% |
| Mar 31, 2022 | -292.72% |
| Dec 31, 2021 | -1,183.67% |
| Sep 30, 2021 | -79,452.56% |